It has already been a busy year for marijuana law! Catch up on key legislative, regulatory, and legal developments affecting the manufacture, distribution, sale, and use of marijuana occurring in 2022, including key decisions...more
During the last two weeks, the U.S. House of Representatives passed two bills aimed at reforming marijuana laws, the Marijuana Opportunity, Reinvestment and Expungement Act (MORE Act) and the Medical Marijuana Research Act...more
Recently, I had the opportunity to moderate panels on cannabis and commercial real estate at programs held in Los Angeles and Chicago. I won’t say it was the best of times or the worst of times, but I will say “it was the...more
2/18/2020
/ Agribusiness ,
Cannabis-Related Businesses (CRBs) ,
Commercial Leases ,
Commercial Tenants ,
Community Development ,
Controlled Substances Act ,
Dispensaries ,
Hemp Related Businesses ,
IRS ,
Landlords ,
Marijuana ,
Marijuana Related Businesses ,
Medical Marijuana ,
Property Owners ,
Recreational Use ,
Security Standards ,
Tax Liability ,
Urban Planning & Development
On June 25, 2018, the Food and Drug Administration (“FDA”) approved Epidiolex (cannabidiol), the first marijuana derived drug for use in the United States, to treat two rare forms of epilepsy....more